Lantheus Medical Investor Relations

At Manningham Medical Centre, you can find all the data about Lantheus Medical Investor Relations. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.

Investor Relations | Lantheus Holdings, Inc.

https://investor.lantheus.com/

Lantheus provides a broad portfolio of products, including PYLARIFY ® (Piflufolastat F18), a PSMA PET imaging agent for the detection of suspected recurrent or metastatic prostate …

Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year …

https://investor.lantheus.com/news-releases/news-release-details/lantheus-holdings-inc-reports-fourth-quarter-and-full-year-2021

NORTH BILLERICA, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully …

Lantheus - Diagnostic and Therapeutic Innovations

https://www.lantheus.com/

Lantheus Presents Data Reinforcing Real-World Clinical Utility of Piflufolastat F 18 PET Scanning in Men with Recurrent Prostate Cancer and Low PSA Levels February 16, 2023 …

Presentation | Lantheus Holdings, Inc.

https://investorday.lantheus.com/presentation

The Investor Relations website contains information about Lantheus Holdings, Inc.'s business for stockholders, potential investors, and financial analysts.

Investor Day | Lantheus Holdings, Inc.

https://investorday.lantheus.com/

The Investor Relations website contains information about Lantheus Holdings, Inc.'s business for stockholders, potential investors, and financial analysts. …

Lantheus to Host Inaugural Investor Day

https://www.globenewswire.com/news-release/2022/03/03/2396763/0/en/Lantheus-to-Host-Inaugural-Investor-Day.html

NORTH BILLERICA, Mass, March 03, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and …

Lantheus to Acquire Progenics to Form a Leading …

https://www.businesswire.com/news/home/20191002005444/en/Lantheus-to-Acquire-Progenics-to-Form-a-Leading-Precision-Diagnostics-Imaging-and-Therapeutics-Company

Lantheus Holdings, Inc. is the parent company of LMI, a global leader in the development, manufacture and commercialization of innovative diagnostic imaging …

Lantheus and Progenics Agree to Amended Transaction …

https://www.businesswire.com/news/home/20200220005672/en/Lantheus-Progenics-Agree-Amended-Transaction-Terms

Progenics Shareholders Will Receive 0.31 Shares of Lantheus Common Stock for Each Share of Progenics Stock in All-Stock Transaction, Represents …

Lantheus Hosts Inaugural Investor Day | Lantheus Holdings, Inc.

https://lantheusholdings.gcs-web.com/news-releases/news-release-details/lantheus-hosts-inaugural-investor-day

Lantheus Outlines Sustainable and Profitable Growth Strategy; Introduces Long-Term Financial Targets. NORTH BILLERICA, Mass., May 16, 2022 (GLOBE …

Need more information about Lantheus Medical Investor Relations?

At Manningham Medical Centre, we collected data on more than just Lantheus Medical Investor Relations. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.